Cytogenetics is a branch of biology, which correlates cytology and genetics. The correlation is used to study chromosomes and genes in cells and tissues. The study is conducted in relation to hereditary and variations in genes and number of chromosomes, which are used for the detection of genetic disorders as well as selection of precise therapies for treatment of these genetic disorders.

The market was valued at $1,121 million in 2017, and is projected to reach $3,097 million in 2025, registering a CAGR of 13.5% from 2018 to 2025.

Cytogenetics includes various techniques such as comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others. These techniques require the use of cytogenetic products such as testing kits, media, and reagents; probes; consumables; instruments; and software & services. These product and techniques are used for the screening of genetic disorders and designing personal medicine.


Download Request Sample @ www.alliedmarketresearch.com/request-sample/2116

Increase in prevalence of cancer & genetic disorders, rise in global geriatric population along with surge in prevalence of chronic diseases, and surge in awareness related to acceptance of personalized medicines across the world are the factors that drive the global cytogenetics market growth. However, higher cost of advanced cytogenetic instruments is expected to impede the market growth.

Conversely, shift from fish to array-based techniques is expected to provide many opportunities during the forecast period. The utilization rate of testing kits, media, and reagents is high, as they are the essential elements of every cytogenetic technique performed. However, the software & services segment is expected to grow at a high CAGR during the forecast period.

Major Players:

• Abbott Laboratories
• Agilent Technologies Inc.
• Applied Spectral Imaging Inc.
• Empire Genomics LLC.
• Illumina Inc.
• Irvine Scientific.

Key findings of the Cytogenetics Market:

• The testing kits, media, and reagents segment accounted for the approximately three-fourths share of the global cytogenetics consumables market in 2017.
• The comparative genomic hybridization segment is expected to grow at a CAGR of 10.5% from 2018 to 2025.
• North America accounted for the majority of the share of the global market revenue in 2017.
• Asia-Pacific is expected to provide lucrative market growth opportunities, registering a CAGR of 12.1% from 2018 to 2025.

Send Enquiry Us @ www.alliedmarketresearch.com/purchase-enquiry/2116

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.